(NASDAQ: ALGN) Align Technology's forecast annual revenue growth rate of 5.31% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.48%.
Align Technology's revenue in 2026 is $4,034,964,000.On average, 20 Wall Street analysts forecast ALGN's revenue for 2026 to be $304,445,985,772, with the lowest ALGN revenue forecast at $290,759,816,428, and the highest ALGN revenue forecast at $323,478,315,016. On average, 20 Wall Street analysts forecast ALGN's revenue for 2027 to be $317,989,590,852, with the lowest ALGN revenue forecast at $299,670,082,928, and the highest ALGN revenue forecast at $339,160,384,056.
In 2028, ALGN is forecast to generate $337,378,330,756 in revenue, with the lowest revenue forecast at $311,574,198,972 and the highest revenue forecast at $369,882,982,948.